Steven Silver
Stock Analyst at Argus Research
(3.46)
# 2,220
Out of 4,361 analysts
22
Total ratings
66.7%
Success rate
16.1%
Average return
Main Sectors:
Stocks Rated by Steven Silver
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintained: Buy | $90 → $104 | $89.50 | +16.20% | 4 | May 13, 2026 | |
| BAX Baxter International | Maintained: Hold | n/a | $18.68 | - | 4 | May 8, 2026 | |
| CAH Cardinal Health | Maintained: Buy | $189 → $248 | $194.88 | +27.26% | 4 | May 5, 2026 | |
| DXCM DexCom | Maintained: Buy | $100 → $90 | $73.45 | +22.53% | 2 | Nov 7, 2025 | |
| ITGR Integer Holdings | Downgraded: Hold | n/a | $90.31 | - | 2 | Oct 24, 2025 | |
| TZOO Travelzoo | Reiterated: Buy | $19 | $10.23 | n/a | 1 | May 11, 2022 | |
| THC Tenet Healthcare | Downgraded: Hold | n/a | $163.60 | n/a | 1 | Jun 13, 2014 | |
| ALNY Alnylam Pharmaceuticals | Rated: Buy | n/a | $286.12 | n/a | 2 | Jan 27, 2014 | |
| GILD Gilead Sciences | Maintained: Buy | $94 | $127.57 | n/a | 1 | Dec 9, 2013 | |
| BKD Brookdale Senior Living | Maintained: Buy | n/a | $12.05 | n/a | 1 | Oct 22, 2010 |
CVS Health
May 13, 2026
Maintained: Buy
Price Target: $90 → $104
Current: $89.50
Upside: +16.20%
Baxter International
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $18.68
Upside: -
Cardinal Health
May 5, 2026
Maintained: Buy
Price Target: $189 → $248
Current: $194.88
Upside: +27.26%
DexCom
Nov 7, 2025
Maintained: Buy
Price Target: $100 → $90
Current: $73.45
Upside: +22.53%
Integer Holdings
Oct 24, 2025
Downgraded: Hold
Price Target: n/a
Current: $90.31
Upside: -
Travelzoo
May 11, 2022
Reiterated: Buy
Price Target: $19
Current: $10.23
Upside: n/a
Tenet Healthcare
Jun 13, 2014
Downgraded: Hold
Price Target: n/a
Current: $163.60
Upside: n/a
Alnylam Pharmaceuticals
Jan 27, 2014
Rated: Buy
Price Target: n/a
Current: $286.12
Upside: n/a
Gilead Sciences
Dec 9, 2013
Maintained: Buy
Price Target: $94
Current: $127.57
Upside: n/a
Brookdale Senior Living
Oct 22, 2010
Maintained: Buy
Price Target: n/a
Current: $12.05
Upside: n/a